Marginated neutrophils in the lungs effectively compete for nanoparticles targeted to the endothelium, serving as a part of the reticuloendothelial system
Marco E. Zamora(Translational Therapeutics (United States)), Edward Cantu(California University of Pennsylvania), Tea Shuvaeva(Translational Therapeutics (United States)), Vladimir R. Muzykantov(Translational Therapeutics (United States)), Joseph D. Planer(Pulmonary and Allergy Associates), Kara L. Spiller(Drexel University), Mortimer Poncz, Jarod A. Zepp(Children's Hospital of Philadelphia), Carolann Espy(Translational Therapeutics (United States)), Aditi Murthy(Pulmonary and Allergy Associates), Serena Omo‐Lamai(Translational Therapeutics (United States)), Maria C. Basil(Brigham and Women's Hospital), Sachchidanand Tiwari(Jawaharlal Nehru University), Evguenia Arguiri(Translational Therapeutics (United States)), Jacob W. Myerson(Translational Therapeutics (United States)), Jia Nong(Translational Therapeutics (United States)), Oscar A. Marcos‐Contreras(Translational Therapeutics (United States)), Lubica Rauova(Children's Hospital of Philadelphia), Kartik Bhamidipati(Translational Therapeutics (United States)), Manthan N. Patel(Translational Therapeutics (United States)), Jichuan Wu(University of Pennsylvania), Fatima Chaudhry(Children's Hospital of Philadelphia), Elizabeth D. Hood(Translational Therapeutics (United States)), Zhicheng Wang(Central South University), Jing Liu(Chinese Academy of Sciences), Hyun‐Jun Kim(Children's Hospital of Philadelphia), Laura T. Ferguson(Pulmonary and Allergy Associates), Eno‐Obong Essien(Translational Therapeutics (United States))
Cited by 1
Related Papers
Specialized pro-resolving mediators: endogenous regulators of infection and inflammation
|Nature reviews. Immunology|2015|743
Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
|American Journal of Respiratory and Critical Care Medicine|2013|686
Control of Endothelial Targeting and Intracellular Delivery of Therapeutic Enzymes by Modulating the Size and Shape of ICAM-1-targeted Carriers
|Molecular Therapy|2008|566
Macrophages of diverse phenotypes drive vascularization of engineered tissues
|Science Advances|2020|280
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
|Molecular Therapy|2021|272